Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Invested Capital (2019 - 2025)

Goldenwell Biotech (GWLL) has disclosed Invested Capital for 7 consecutive years, with -$94823.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Invested Capital fell 592.87% year-over-year to -$94823.0, compared with a TTM value of -$94823.0 through Sep 2025, down 592.87%, and an annual FY2024 reading of -$47241.0, down 155.76% over the prior year.
  • Invested Capital was -$94823.0 for Q3 2025 at Goldenwell Biotech, down from -$86838.0 in the prior quarter.
  • Across five years, Invested Capital topped out at $372594.0 in Q1 2021 and bottomed at -$94823.0 in Q3 2025.
  • Average Invested Capital over 5 years is $135183.3, with a median of $140929.0 recorded in 2023.
  • The sharpest move saw Invested Capital soared 48.11% in 2021, then crashed 2369.68% in 2025.
  • Year by year, Invested Capital stood at $301713.0 in 2021, then crashed by 33.18% to $201618.0 in 2022, then tumbled by 57.98% to $84723.0 in 2023, then crashed by 155.76% to -$47241.0 in 2024, then crashed by 100.72% to -$94823.0 in 2025.
  • Business Quant data shows Invested Capital for GWLL at -$94823.0 in Q3 2025, -$86838.0 in Q2 2025, and -$81618.0 in Q1 2025.